Annette Brandt

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications

TNFα is a trigger of aging-associated liver inflammation in mice.

TNFα is a trigger of aging-associated liver inflammation in mice.

Journal: npj aging
Published: October 22, 2025

Islet Inflammation and Endocrine Function in Aging - Evaluating the Role of Toll-like receptor 4.

Islet Inflammation and Endocrine Function in Aging - Evaluating the Role of Toll-like receptor 4.

Journal: Aging and disease
Published: September 04, 2025

The nutrition toolbox permits in silico generation, analysis, and optimization of personalized diets through metabolic modelling.

The nutrition toolbox permits in silico generation, analysis, and optimization of personalized diets through metabolic modelling.

Journal: Bioinformatics advances
Published: August 12, 2025

Toll-like receptor 2 drives liver senescence and fibrosis in aging through gut-derived microbial signaling.

Toll-like receptor 2 drives liver senescence and fibrosis in aging through gut-derived microbial signaling.

Journal: Cellular & molecular biology letters
Published: August 01, 2025

Fiber enrichment is not superior to dietary monitoring in MASLD: A dual-center, double-blind, placebo-controlled trial.

Fiber enrichment is not superior to dietary monitoring in MASLD: A dual-center, double-blind, placebo-controlled trial.

Journal: iScience
Published: June 18, 2025

Aging-related decline in the liver and brain is accelerated by refined diet consumption.

Aging-related decline in the liver and brain is accelerated by refined diet consumption.

Journal: GeroScience
Published: February 17, 2025

Honokiol, a Neolignan from Magnolia officinalis, Attenuated Fructose-Induced Hepatic Fat Accumulation by Improving Intestinal Barrier Function in Mice.

Honokiol, a Neolignan from Magnolia officinalis, Attenuated Fructose-Induced Hepatic Fat Accumulation by Improving Intestinal Barrier Function in Mice.

Journal: The Journal of nutrition
Published: November 11, 2024

Oral supplementation of melatonin attenuates the onset of alcohol-related liver disease.

Oral supplementation of melatonin attenuates the onset of alcohol-related liver disease.

Journal: Journal of molecular medicine (Berlin, Germany)
Published: August 27, 2024

A weekly 4-methylpyrazole treatment attenuates the development of non-obese metabolic dysfunction-associated steatotic liver disease (MASLD) in male mice: Role of JNK.

A weekly 4-methylpyrazole treatment attenuates the development of non-obese metabolic dysfunction-associated steatotic liver disease (MASLD) in male mice: Role of JNK.

Journal: European journal of clinical investigation
Published: May 13, 2024

Long Noncoding RNAs in Diet-Induced Metabolic Diseases.

Long Noncoding RNAs in Diet-Induced Metabolic Diseases.

Journal: International journal of molecular sciences
Published: April 15, 2024

Oral supplementation of choline attenuates the development of alcohol-related liver disease (ALD).

Oral supplementation of choline attenuates the development of alcohol-related liver disease (ALD).

Journal: Molecular medicine (Cambridge, Mass.)
Published: March 28, 2024

MASLD is related to impaired alcohol dehydrogenase (ADH) activity and elevated blood ethanol levels: Role of TNFα and JNK.

MASLD is related to impaired alcohol dehydrogenase (ADH) activity and elevated blood ethanol levels: Role of TNFα and JNK.

Journal: Redox biology
Published: February 14, 2024
Showing 1-12 of 47

Last Updated: 09/26/2026